Brussels, 21/08/2001 (Agence Europe) - In a statement issued last Friday, the president of the European Commission, Romano Prodi, stressed that the marketing of the anti-cholesterol medicine by Bayer was authorised through decentralised procedure and that the responsibility for the safety of this product lies fully with Member States . He noted that the European rapid warning procedure has worked well and that the Commission acted promptly to ensure that safety measures were taken by Member...